Drug Shortage Report for LINEZOLID INJECTION

Last updated on 2019-09-14 History
Report ID 90630
Drug Identification Number 02430827
Brand name LINEZOLID INJECTION
Common or Proper name Linezolid
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) LINEZOLID
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 300mL
ATC code J01XX
ATC description OTHER ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-08-02
Actual start date
Estimated end date 2019-08-30
Actual end date 2019-09-13
Shortage status Resolved
Updated date 2019-09-14
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-09-14 English Compare
v5 2019-09-13 French Compare
v4 2019-09-13 English Compare
v3 2019-08-03 English Compare
v2 2019-08-02 French Compare
v1 2019-08-02 English Compare